More SEC Filings
View Older Stories View Newer Stories-
Form 4 TREACE MEDICAL CONCEPTS, For: Jan 22 Filed by: Elder Scot Michael
-
Form 4 TREACE MEDICAL CONCEPTS, For: Jan 21 Filed by: Scanlan Sean F.
-
Form 4 KULR Technology Group, For: Jan 21 Filed by: Canter Shawn
-
Form 4 TREACE MEDICAL CONCEPTS, For: Jan 22 Filed by: Guglielmino Gaetano
-
Form X-17A-5 ONPEAK CAPITAL LLC For: Dec 31
-
Form 3 SentinelOne, Inc. For: Jan 16 Filed by: PADGETT BARRY L.
-
Form 4 SCHWAB CHARLES CORP For: Jan 22 Filed by: Beatty Jonathan S
-
Form 4 Byrna Technologies Inc. For: Jan 22 Filed by: Rooney Emily
-
Form 4 Byrna Technologies Inc. For: Jan 22 Filed by: Reed Chris Lavern
-
Form 4 Byrna Technologies Inc. For: Jan 22 Filed by: ELMORE LEONARD J
-
Form 4 Byrna Technologies Inc. For: Jan 22 Filed by: Hughes Herbert
-
Form SCHEDULE 13D/A ASA Gold & Precious Meta Filed by: Saba Capital Management, L.P.
-
Form 4 GLAUKOS Corp For: Jan 21 Filed by: Gilliam Joseph E
-
Form 4 Public Storage For: Jan 22 Filed by: REYES JOHN
-
Form 4 PodcastOne, Inc. For: Sep 11 Filed by: LiveOne, Inc.
-
Form 4 Quince Therapeutics, For: Jan 23 Filed by: Thye Dirk
-
Form 4 Dakota Gold Corp. For: Jan 23 Filed by: QUARTERMAIN ROBERT
-
Form 4/A ENTRAVISION COMMUNICATIO For: Jan 15 Filed by: Christenson Michael J
-
Form 4 Quince Therapeutics, For: Jan 23 Filed by: Ryan Charles S.
-
Form 144 Taysha Gene Therapies, Filed by: Nolan Sean P.
-
Form 4 Quince Therapeutics, For: Jan 23 Filed by: Hannah Brendan
-
Form 144 Taysha Gene Therapies, Filed by: Nagendran Sukumar
-
Form 144 Taysha Gene Therapies, Filed by: Nagendran Sukumar
-
Form 144 Taysha Gene Therapies, Filed by: Haque-Ahmed Rumana
-
Form 144 Taysha Gene Therapies, Filed by: Porter Fred
-
Form 4 PROCORE TECHNOLOGIES, For: Jan 21 Filed by: O CONNOR KEVIN J
-
Form 144 Taysha Gene Therapies, Filed by: McGinnis Emily
-
Form 4 ENTRAVISION COMMUNICATIO For: Jan 21 Filed by: Navarro Juan
-
Form 4 ENTRAVISION COMMUNICATIO For: Jan 21 Filed by: JEFFERY LIBERMAN A
-
Form 4 ENTRAVISION COMMUNICATIO For: Jan 21 Filed by: Boelke Mark
-
Form 4 ENTRAVISION COMMUNICATIO For: Jan 21 Filed by: Boelke Mark
-
Form 144 Taysha Gene Therapies, Filed by: McAuliffe Sean
-
Form 144 Taysha Gene Therapies, Filed by: McAuliffe Sean
-
Form 144 Taysha Gene Therapies, Filed by: Alam Kamran
-
Form 144 Taysha Gene Therapies, Filed by: Alam Kamran
-
Form 4 QT IMAGING HOLDINGS, For: Jan 22 Filed by: Katz Avi S
-
Form 4 QT IMAGING HOLDINGS, For: Jan 22 Filed by: Katz Avi S
-
Form 4 Alphabet Inc. For: Jan 21 Filed by: Pichai Sundar
-
Form 4 BITGO HOLDINGS, INC. For: Aug 15 Filed by: BROOKS BRIAN P
-
Form 4 BITGO HOLDINGS, INC. For: Sep 06 Filed by: Evans Justin
-
Form 4 BITGO HOLDINGS, INC. For: Sep 06 Filed by: Parasuraman Sunita
-
Form 4 ENDRA Life Sciences Inc. For: Jan 21 Filed by: DIGIANDOMENICO ANTHONY
-
Form 4 BITGO HOLDINGS, INC. For: Jul 21 Filed by: Mettler Jody
-
Form 4 ENDRA Life Sciences Inc. For: Jan 21 Filed by: Harsh Michael
-
Form 4 ENDRA Life Sciences Inc. For: Jan 21 Filed by: Jacroux Richard
-
Form 4 ENDRA Life Sciences Inc. For: Jan 21 Filed by: Basenese Lou
-
Form 4 BITGO HOLDINGS, INC. For: Jan 21 Filed by: Horowitz Jeff Peter
-
Form 4 ENDRA Life Sciences Inc. For: Jan 21 Filed by: Tokman Alexander Y
-
Form 4 BITGO HOLDINGS, INC. For: Sep 30 Filed by: Belshe Michael
-
Form 4 BITGO HOLDINGS, INC. For: Sep 17 Filed by: Reginelli Edward

